Corrigendum to ‘An olive polyphenol-based nutraceutical improves cutaneous manifestations of psoriasis in humans’ PharmaNutrition 4 (2016) 151–153 (PharmaNutrition (2016) (4)(151–153)(S2213434416300640)(10.1016/j.phanu.2016.10.002));An olive polyphenol-based nutraceutical improves cutaneous manifestations of psoriasis in humans

PharmaNutrition

Volumn 4, Issue 4, 2016, Pages 151-153

  Herrera Acosta, E ^a,b   Alonso Suarez Perez J ^a   Aguilera Arjona, J ^a   Visioli, F ^c,d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Hospital Xanit Internacional   (Spain)

^c CSIC   (Spain)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cosmeceuticals; Hydroxytyrosol; Nutraceuticals; Olive phenols; Psoriasis; Skin care

Indexed keywords

ALYVIUM; BIOTIN; MALTODEXTRIN; NUTRACEUTICAL; PLACEBO; POLYPHENOL; RETINOL; RIBOFLAVIN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL;

EID: 84995772480     PISSN: None     EISSN: 22134344     Source Type: Journal    
DOI: 10.1016/j.phanu.2018.01.002     Document Type: Erratum

References (18)

1. [1] Schleicher, S.M., Psoriasis: pathogenesis, assessment, and therapeutic update. Clin. Podiatr. Med. Surg. 33 (2016), 355–366.
2. [2] Gottlieb, A.B., Greb, J.E., Goldminz, A.M., Psoriasis trends and practice gaps. Dermatol. Clin. 34 (2016), 235–242.
3. [3] Frieder, J., Ryan, C., Psoriasis and cardiovascular disorders. G. Ital. Dermatol. Venereol. 151 (2016), 678–693.
4. [4] Uluckan, O., Wagner, E.F., Chronic systemic inflammation originating from epithelial tissues. FEBS J., 2016, 10.1111/febs.13904.
5. [5] Bernardini, E., Visioli, F., High quality, good health: the case for olive oil. Eur. J. Lipid Sci. Technol., 2016, 10.1002/ejlt.201500505 (in press).
6. [6] The EFSA Panel on Dietetic Products. Scientific opinion on the substantiation of health claims related to polyphenols in olive and protection of ldl particles from oxidative damage (id 1333, 1638, 1639, 1696, 2865), maintenance of normal blood hdl cholesterol concentrations (id 1639), maintenance of normal blood pressure (id 3781), anti-inflammatory properties (id 1882), contributes to the upper respiratory tract health (id 3468), can help to maintain a normal function of gastrointestinal tract (3779), and contributes to body defences against external agents (id 3467) pursuant to article 13(1) of regulation (ec) no 1924/2006. EFSA J. 2009, 9, 2033–2058.
7. [7] Ursini, F., Maiorino, M., Forman, H.J., Redox homeostasis: the golden mean of healthy living. Redox Biol. 8 (2016), 205–215.
8. [8] Visioli, F., Xenobiotics and human health: a new view of their pharma-nutritional role. PharmaNutrition 3 (2015), 60–64.
9. [9] Chiva-Blanch, G., Visioli, F., Polyphenols and health: moving beyond antioxidants. J. Berry Res. 2 (2012), 63–71.
10. [10] Guallar, E., Stranges, S., Mulrow, C., Appel, L.J., Miller, E.R. 3rd, Enough is enough: stop wasting money on vitamin and mineral supplements. Ann. Intern. Med. 159 (2013), 850–851.
11. [11] Crespo, M.C., Tome-Carneiro, J., Burgos-Ramos, E., Loria Kohen, V., Espinosa, M.I., Herranz, J., Visioli, F., One-week administration of hydroxytyrosol to humans does not activate phase ii enzymes. Pharmacol. Res. 95–96 (2015), 132–137.
12. [12] Barygina, V.V., Becatti, M., Soldi, G., Prignano, F., Lotti, T., Nassi, P., Wright, D., Taddei, N., Fiorillo, C., Altered redox status in the blood of psoriatic patients: involvement of nadph oxidase and role of anti-tnf-alpha therapy. Redox Rep. 18 (2013), 100–106.
13. [13] Jones, D.P., Sies, H., The redox code. Antioxid. Redox Signal. 23 (2015), 734–746.
14. [14] Famenini, S., Goh, C., Evidence for supplemental treatments in androgenetic alopecia. J. Drugs Dermatol. 13 (2014), 809–812.
15. [15] Bailey, E.E., Ference, E.H., Alikhan, A., Hession, M.T., Armstrong, A.W., Combination treatments for psoriasis: a systematic review and meta-analysis. Arch. Dermatol. 148 (2012), 511–522.
16. [16] Ashoori, M., Saedisomeolia, A., Riboflavin (vitamin B(2)) and oxidative stress: a review. Br. J. Nutr. 111 (2014), 1985–1991.
17. [17] Visioli, F., Wolfram, R., Richard, D., Abdullah, M.I., Crea, R., Olive phenolics increase glutathione levels in healthy volunteers. J. Agric. Food Chem. 57 (2009), 1793–1796.
18. [18] Prussick, R., Prussick, L., Gutman, J., Psoriasis improvement in patients using glutathione-enhancing, nondenatured whey protein isolate: a pilot study. J. Clin. Aesthet. Dermatol. 6 (2013), 23–26.